Leukemia stem cells protect themselves against the immune defense by suppressing a target molecule for killer cells. This protective mechanism can be tricked with drugs. In the journal "Nature", scientists from Basel, Tübingen and Heidelberg describe the new therapeutic approaches that can ... more
Prof. Dr. Michael Lämmerhofer
Eberhard-Karls-Universität Tübingen, Pharmazeutisches Institut
Michael Lämmerhofer studied pharmacy at the University of Graz, receiving his doctorate in pharmaceutical chemistry in 1996. This was followed by a move to the University of Vienna, where, with the exception of a one-year postdoc at the University of Berkeley (from 1999 to 2000), his positions included those of research assistant, university lecturer and associate professor at the University’s Institute of Analytical Chemistry. After completing his habilitation in 2002, he also headed the Christian Doppler Lab for Molecular Recognition Materials in Vienna from 2002 to 2009. In 2012, he accepted a professorship in Pharmaceutical Analysis and Bioanalysis in the Institute of Pharmaceutical Sciences (Faculty of Mathematics and Natural Sciences) at the University of Tübingen. His research work focuses on the analysis of enantiomers, biopharmaceuticals and biomarkers, as well as the development of functionalized separator materials. Michael Lämmerhofer is an Associate Editor of the Journal of Separation Science and the holder of six patents.